There is a need for independent studies about new oral anticoagulants in atrial fibrillation patients

Int J Cardiol. 2014;172(1):e119-20. doi: 10.1016/j.ijcard.2013.12.118. Epub 2014 Jan 4.

Authors

Claudia Stöllberger¹, Birke Schneider², Josef Finsterer³

Affiliations

¹ Krankenanstalt Rudolfstiftung, Juchgasse 25, A-1030 Wien, Austria. Electronic address: claudia.stoellberger@chello.at.
² Sana Kliniken Lübeck GmbH, Kronsforder Allee 71-73, 23560 Lübeck, Germany.
³ Krankenanstalt Rudolfstiftung, Juchgasse 25, A-1030 Wien, Austria.

PMID: 24439870
DOI: 10.1016/j.ijcard.2013.12.118

No abstract available

Publication types

Letter
Review

MeSH terms

Administration, Oral
Anticoagulants / administration & dosage*
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / epidemiology
Clinical Trials as Topic / trends
Humans
Stroke / epidemiology
Stroke / prevention & control*

Substances

Anticoagulants